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sAbstract: 
Objective: To determine H. pylori prevalence in patients suffering from non ulcer dyspepsia by doing rapid urease 
test, histopathology of gastric biopsy and serology. 
Place and duration: In the Medicine Unit II of Jinnah Hospital, Lahore for one year duration from March 2018 to 
March 2019. 
Methods: Rapid urease test, serology test and gastric biopsy histopathology for H. Pylori were performed in 50 
patients with ulcer-like symptoms in both sexes but no evidence of peptic ulcer disease on gastroscopy. 
Results: H. Pylori was detected in gastric biopsy histopathology in 33 patients (66%). 95% CI was 51.14% to 78.41%. 
Serological test was positive in 36 patients (72%). 95% CI was 50.30% to 76.31%. In 35 patients (70%); rapid urease 
test was positive. The 95% confidence interval was 55.21% to 81.71%. 
Conclusion: Rapid urease test and serological test for H. Pylori may provide good diagnostic performance in subjects 
with non-ulcer dyspepsia in our inhabitants. 
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INTRODUCTION: 
Since characterized by Marshall and Warren in 1983, 
Helicobacter pylori has been discovered to cause 
gastritis, peptic ulcer and gastric carcinoma1-3. The H. 
Pylori complete role in non-ulcer dyspepsia is still 
speculative. However, it has been connected with non-
ulcer dyspepsia, and large published data suggest that 
H. Pylori is etiologically related with non-ulcer 
dyspepsia4-6. Invasive and non-invasive tests can be 
performed to diagnose H. pylori infection7-8. In this 
study, serology, rapid urease test and histopathological 
methods were used as diagnostic tools. This study will 
help to understand the H. Pylori prevalence in our 
dyspeptic patients and, if high, will support the need to 
investigate dyspeptic patients. It will also be useful to 
evaluate the effectiveness of the various tests used for 
diagnosis9. 
 
MATERIALS AND METHODS:  
This Prospective study was held in the Medicine Unit 
II of Jinnah Hospital, Lahore for one year duration 
from March 2018 to March 2019. 
 
Inclusion criteria: 
1. 50 patients were included in the study. There were 
recurrent or persistent pain or discomfort symptoms in 
the upper abdomen, such as indigestion, early 
saturation, heartburn, insufficiency, water, belching, 
nausea, and vomiting. 
2. These patients underwent physical examination and 
research; ie CBC, liver function tests, ECG, urea 
creatinine, S / amylase, abdominal ultrasound. Only 
patients with the above-mentioned normal tests were 
included. 
3. Patients without evidence of peptic ulcer on upper 
digestive endoscopy.  
 
Exclusion Criteria: 
1. Patients with chronic liver disease, upper 
gastrointestinal bleeding, hepatic encephalopathy, 
pancreatic disease, gallbladder disease or severe 
concurrent disease were excluded from the study. 
2. Patients with a history of NSAID intake, 
erythromycin theophylline. 
3. Patients who had H. Pylori treatment history in the 
last month were excluded from the study. Patients who 
encountered the above standards were subjected to 
histopathology of serology, rapid urease test and 
gastric biopsy as described below: 
 a) Serology: Serological testing was performed using 
the best H. Pylori test disc. A commercially available 
step. To obtain serum, 2 cc patient's blood was 
centrifuged and 2-3 drops of sample were placed into 
the well of the kit. The results were interpreted after 10 
minutes. When the test started, a purple color was seen 
in the result window. If two color bands appear in the 
results window, the test is declared positive. The test 
was declared negative when only one color band 
appears in the results window. If a purple band does 
not appear in the results window, the test is declared 
invalid.  
b) Gastric biopsy histopathology: gastroscopy was 
performed to perform gastric biopsy. The procedure 
was performed with the help of Olympus Gastroscope 
GIF E. Four gastric and gastric antrum biopsies were 
taken. Two gastric biopsies (sample # 1) were placed 
in formalin solution and taken to the Histopathology 
Department where they were stained with eosin, 
giemsa and hematoxylin. The remaining 2 biopsies 
(sample no. 2) were provided for rapid urease tests. 
Rapid urease test Procedure steps 
1. To perform a rapid urease test, a CHRISTENSENS 
UREA BROTH (OXOID) solution from the 
Department of Pathology was introduced. It was 
yellow in its original color. 
2. Rapid urease solutions were added to the test tubes 
and placed at 4 ° C in the refrigerator in the endoscopy 
room. After preparation of the solution, the solution 
was used for five days and then a new Christenson 
broth was prepared. 
3. Two gastric biopsies (example # 2) of the body and 
antrum were added to a test tube containing rapid 
urease solutions. The results of the rapid urease test 
were interpreted after 2 hours and after 24 hours. 
However, the final result was evaluated at 24 hours. 
The change in color of the RUT solution is yellow to 
pink or magenta positive; If there is no color change, 
RUT declared negative. 
 
RESULTS: 
Fifty patients of both sexes were included in the study 
with age ranged from 21 to 65 years. Total number of 
male patients was 30 (60%) and number of female 
patients was 20 (40%). (Table 1). 
IAJPS 2019, 06 (08), 14913-14917                   Abdul Manan et al                     ISSN 2349-7750 
 
 
w w w . i a j p s . c o m  
 
Page 14915 
 
 
Serology results: In 36 of 50 patients (72%), the 
serological test was positive 10 minutes after the start 
of the test. Twenty patients (40%) were men and 16 
(32%) were women (95% CI. The positivity of H. 
Pylori with serology was 50.30% to 76.31%) (Table 
2). 
 
 
 
Rapid urease test results: After 24 hours, rapid urease 
test was positive in 50 patients in 35 patients (70%). 
Of these 35 patients, 28 were positive after starting the 
test at the end of the first two hours, and 7 were 
positive 24 hours after starting the test. 17 patients 
(34%) were males and 18 patients (36%) were females 
(95% CI: H. Pylori positivity with RUT was 55.22% 
to 81.71%) (Table 3). 
 
 
 
Histopathological results: H. Pylori was detected in 33 
patients (66%) on histopathology of gastric biopsy. 
Nineteen patients (38%) were male and 14 (28%) 
female (95% CI for H. Pylori positivity, 51.14% to 
78.41% due to histopathology) (Table 4). 
 
 
 
DISCUSSION: 
H.Pylori has been shown to be associated with gastric 
peptic ulcer disease, gastric carcinoma and other extra-
gastrointestinal diseases [10-11]. However, the exact 
role of H. Pylori in non-ulcer dyspepsia remains 
controversial [12]. Many studies have been conducted 
to establish a link between H. Pylori and non-ulcer 
dyspepsia in Western countries and Pakistan. The 
results of some foreign studies show that H. Pylori has 
no role in non-ulcer dyspepsia. However, other foreign 
studies associate H. Pylori with dyspepsia without 
ulcers and show evidence that H. pylori plays an 
etiological role in dyspepsia without ulcers [13]. In this 
study, H. Pylori was detected in 66% of patients with 
gastric biopsy histopathology. 70% of patients had 
rapid positive urease test and 72% of patients had 
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positive serology [14]. The results of this study are 
supported by studies conducted in other parts of 
Pakistan. Javed Iqbal et al. He found that gastric 
biopsy in H. Pylori was positive in 80% and rapid 
urease test was positive in 63% of patients with 
dyspepsia. Najmul Hassan Sheikh showed H. Pylori 
on gastric biopsy in 87% of patients with dyspepsia. 
Guhu Sarver et al. He conducted a research in 
Balochistan and identified H. Pylori by serological 
method in 71% (72%) of dyspeptic patients very close 
to serological outcomes by K. Hameed et al. conducted 
a study in Peshawar and demonstrated that 74% of 
patients with dyspepsia had H. Pylori infection [14]. 
H. Pylori is common at different frequencies in 
different parts of the world. There is a high proportion 
of H. Pylori in Pakistan and other developing 
countries. For example, Parsad et al. reported that 
71.4% of non-ulcer dyspepsia cases were positive for 
H. Pylori in India. A review of the Western literature 
shows that the prevalence of H. Pylori in dyspeptic 
patients ranges from 30% to 70%. The prevalence in 
developed countries is lower than in developing 
countries. This is evident in studies by Gregson et al., 
Rokkas, who found that H. Pylori was 55 to 37% in 
patients with dyspepsia, respectively [15]. 
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